MedPath

Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project

Recruiting
Conditions
Lung Cancer
Registration Number
NCT02613637
Lead Sponsor
University of Ulm
Brief Summary

Registry Study on Biological Disease Profile and Clinical Outcome in Patients with Newly Diagnosed or Existent Lung Cancer

The LuCa Biology and Outcome (BiO)-Project

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Patients with suspected diagnosis of lung cancer, or previously diagnosed lung cancer
  • Age ≥ 18 years. There is no upper age limit.
Exclusion Criteria
  • Severe neurological or psychiatric disorder interfering with ability to give an informed consent
  • No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation
  • No consent for biobanking of patient's biological specimens and performance of analyses on stored material.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall Survivalmaximally 10 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Klinikum Esslingen GmbH

🇩🇪

Esslingen, Germany

Pneumologie, Internistische Intensivmedizin, Beatmungsmedizin und Allgemeine Innere Medizin, Krankenhaus vom Roten Kreuz Bad Cannstatt GmbH

🇩🇪

Stuttgart, Germany

Universitätsklinikum Ulm

🇩🇪

Ulm, Germany

© Copyright 2025. All Rights Reserved by MedPath